U.S. flag

An official website of the United States government

NM_000284.4(PDHA1):c.648A>C (p.Leu216Phe) AND Pyruvate dehydrogenase E1-alpha deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 9, 2002
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000011640.11

Allele description [Variation Report for NM_000284.4(PDHA1):c.648A>C (p.Leu216Phe)]

NM_000284.4(PDHA1):c.648A>C (p.Leu216Phe)

Gene:
PDHA1:pyruvate dehydrogenase E1 subunit alpha 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp22.12
Genomic location:
Preferred name:
NM_000284.4(PDHA1):c.648A>C (p.Leu216Phe)
HGVS:
  • NC_000023.11:g.19355393A>C
  • NG_016781.1:g.16501A>C
  • NM_000284.4:c.648A>CMANE SELECT
  • NM_001173454.2:c.762A>C
  • NM_001173455.2:c.669A>C
  • NM_001173456.2:c.555A>C
  • NP_000275.1:p.Leu216Phe
  • NP_001166925.1:p.Leu254Phe
  • NP_001166926.1:p.Leu223Phe
  • NP_001166927.1:p.Leu185Phe
  • NC_000023.10:g.19373511A>C
Protein change:
L185F; LEU216PHE
Links:
OMIM: 300502.0023; dbSNP: rs121917898
NCBI 1000 Genomes Browser:
rs121917898
Molecular consequence:
  • NM_000284.4:c.648A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001173454.2:c.762A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001173455.2:c.669A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001173456.2:c.555A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Pyruvate dehydrogenase E1-alpha deficiency (PDHAD)
Synonyms:
X-linked Leigh syndrome; ATAXIA, INTERMITTENT, WITH PYRUVATE DEHYDROGENASE DEFICIENCY; ATAXIA WITH LACTIC ACIDOSIS I; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010717; MedGen: C1839413; OMIM: 312170

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000031872OMIM
no assertion criteria provided
Pathogenic
(Oct 9, 2002)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region.

Naito E, Ito M, Yokota I, Saijo T, Matsuda J, Ogawa Y, Kitamura S, Takada E, Horii Y, Kuroda Y.

Biochim Biophys Acta. 2002 Oct 9;1588(1):79-84.

PubMed [citation]
PMID:
12379317

Details of each submission

From OMIM, SCV000031872.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a male patient with thiamine-responsive pyruvate dehydrogenase E1-alpha deficiency (PDHAD; 312170), Naito et al. (2002) identified a 648A-C transversion in exon 7 of the PDHA1 gene, resulting in a leu216-to-phe (L216F) substitution within the thiamine pyrophosphate-binding region. The patient's mother was heterozygous for the mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022